BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Endo S, Matsunaga T, Nishinaka T. The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites 2021;11:332. [PMID: 34063865 DOI: 10.3390/metabo11060332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Rajak S, Gupta P, Anjum B, Raza S, Tewari A, Ghosh S, Tripathi M, Singh BK, Sinha RA. Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. Biochim Biophys Acta Mol Basis Dis 2021;:166319. [PMID: 34954342 DOI: 10.1016/j.bbadis.2021.166319] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chabert C, Vitte AL, Iuso D, Chuffart F, Trocme C, Buisson M, Poignard P, Lardinois B, Debois R, Rousseaux S, Pepin JL, Martinot JB, Khochbin S. AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome. Int J Mol Sci 2022;23:1911. [PMID: 35163833 DOI: 10.3390/ijms23031911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Westermann M, Adomako-bonsu AG, Thiele S, Çiçek SS, Martin H, Maser E. Inhibition of human carbonyl reducing enzymes by plant anthrone and anthraquinone derivatives. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109823] [Reference Citation Analysis]
4 Ruiz FX, Parés X, Farrés J. Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition. Metabolites 2021;11:865. [PMID: 34940623 DOI: 10.3390/metabo11120865] [Reference Citation Analysis]
5 Endo S, Morikawa Y, Matsunaga T, Hara A, Nishinaka T. Porcine aldo-keto reductase 1 C subfamily members AKR1C1 and AKR1C4: Substrate specificity, inhibitor sensitivity and activators. J Steroid Biochem Mol Biol 2022;:106113. [PMID: 35398259 DOI: 10.1016/j.jsbmb.2022.106113] [Reference Citation Analysis]
6 He Y, Walsh CM. Editorial: Editor’s Pick 2021: Highlights in Cell Death and Survival. Front Cell Dev Biol 2022;10:887688. [DOI: 10.3389/fcell.2022.887688] [Reference Citation Analysis]
7 Zhang Y, Knatko EV, Higgins M, Dayalan Naidu S, Smith G, Honda T, de la Vega L, Dinkova-kostova AT. Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal Tumors. Antioxidants 2022;11:262. [DOI: 10.3390/antiox11020262] [Reference Citation Analysis]
8 Xu B, Peng Z, An Y, Yan G, Yao X, Guan L, Sun M. Identification of Energy Metabolism-Related Gene Signatures From scRNA-Seq Data to Predict the Prognosis of Liver Cancer Patients. Front Cell Dev Biol 2022;10:858336. [DOI: 10.3389/fcell.2022.858336] [Reference Citation Analysis]
9 Pohjanvirta R, Nasri A. The Potent Phytoestrogen 8-Prenylnaringenin: A Friend or a Foe? Int J Mol Sci 2022;23:3168. [PMID: 35328588 DOI: 10.3390/ijms23063168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Saeed A, Ejaz SA, Sarfraz M, Tamam N, Siddique F, Riaz N, Qais FA, Chtita S, Iqbal J. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer. Molecules 2022;27:3981. [DOI: 10.3390/molecules27133981] [Reference Citation Analysis]
11 Shao X, Wu J, Yu S, Zhou Y, Zhou C. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. Aging (Albany NY) 2021;13:22298-314. [PMID: 34552036 DOI: 10.18632/aging.203538] [Reference Citation Analysis]